ArticlePatterns (New York, N.Y.)2026
Modeling of longitudinal immune profiles reveals distinct immunogenic signatures following five COVID-19 vaccinations among people living with HIV.
Article in Patterns (New York, N.Y.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The immune response to vaccination is highly heterogeneous and arises from a dynamic interplay of immune components. Harnessing machine learning (ML) to learn immune interdependencies offers the potential not only to decode immune signatures linked to a specified comorbidity but also to reveal individualized patterns laying the groundwork for precision-guided vaccination and targeted clinical follow-up. We employ a random forest (RF) approach to classify informative differences in immunogenicity between older people living with HIV (PLWH) on antiretroviral therapy (ART) and an age-matched control group who received up to five SARS-CoV-2 vaccinations. RFs identify evidence for T helper 1 (Th1) imprinting and reveal novel distinguishing immune features, such as saliva-based antibody screening, as promising diagnostic tools (whereas serum IgG is not). Our modeling approach reveals a subset of PLWH whose immune signatures are indistinguishable from the HIV- control group, which we interpret as near-complete immune restoration from a longitudinal vaccine-elicited immunogenic perspective. To expand the utility of our findings, we generate privacy-preserving synthetic "virtual patients" that accurately approximate the original longitudinal immunologic data and show, via train-on-synthetic/test-on-real evaluation, that RF classifiers trained solely on virtual patients generalize to held-out real patients. Our results highlight the effectiveness in utilizing informative immune feature interdependencies for classification tasks and suggest broad impacts of ML applications for personalized vaccination strategies among high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.